Your browser doesn't support javascript.
loading
BGJ398, A Pan-FGFR Inhibitor, Overcomes Paclitaxel Resistance in Urothelial Carcinoma with FGFR1 Overexpression.
Kim, Se Hyun; Ryu, Haram; Ock, Chan-Young; Suh, Koung Jin; Lee, Ji Yun; Kim, Ji-Won; Lee, Jeong-Ok; Kim, Jin Won; Kim, Yu Jung; Lee, Keun-Wook; Bang, Soo-Mee; Kim, Jee Hyun; Lee, Jong Seok; Ahn, Joong Bae; Kim, Kui-Jin; Rha, Sun Young.
Afiliación
  • Kim SH; Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam 13620, Korea. sehyunkim@snubh.org.
  • Ryu H; Department of Medicine, Graduate School of Yonsei University, Seoul 03722, Korea. sehyunkim@snubh.org.
  • Ock CY; Medical Research Collaborating Center, Seoul National University Bundang Hospital, Seongnam 13605, Korea. r2218@snubh.org.
  • Suh KJ; Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam 13620, Korea. ock.chanyoung@gmail.com.
  • Lee JY; Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam 13620, Korea. skjmd0919@snubh.org.
  • Kim JW; Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam 13620, Korea. maimatin83@snubh.org.
  • Lee JO; Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam 13620, Korea. jiwonkim@snubh.org.
  • Kim JW; Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam 13620, Korea. deafkeller@snubh.org.
  • Kim YJ; Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam 13620, Korea. jwkim@snubh.org.
  • Lee KW; Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam 13620, Korea. cong1005@snubh.org.
  • Bang SM; Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam 13620, Korea. hmodoctor@snubh.org.
  • Kim JH; Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam 13620, Korea. 65368@snubh.org.
  • Lee JS; Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam 13620, Korea. jhkimmd@snubh.org.
  • Ahn JB; Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam 13620, Korea. jslee@snubh.org.
  • Kim KJ; Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul 03722, Korea. vvswm513@yuhs.ac.
  • Rha SY; Medical Research Collaborating Center, Seoul National University Bundang Hospital, Seongnam 13605, Korea. 99264@snubh.org.
Int J Mol Sci ; 19(10)2018 Oct 15.
Article en En | MEDLINE | ID: mdl-30326563
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Compuestos de Fenilurea / Pirimidinas / Expresión Génica / Paclitaxel / Resistencia a Antineoplásicos / Inhibidores de Proteínas Quinasas / Receptor Tipo 1 de Factor de Crecimiento de Fibroblastos Límite: Humans Idioma: En Revista: Int J Mol Sci Año: 2018 Tipo del documento: Article Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Compuestos de Fenilurea / Pirimidinas / Expresión Génica / Paclitaxel / Resistencia a Antineoplásicos / Inhibidores de Proteínas Quinasas / Receptor Tipo 1 de Factor de Crecimiento de Fibroblastos Límite: Humans Idioma: En Revista: Int J Mol Sci Año: 2018 Tipo del documento: Article Pais de publicación: Suiza